Scrip
Market Insight - In search of a gold standard in MS
18 June 2009
Dr Andrea Taylor
Advanced dosage and delivery technologies promise improved quality of life for multiple sclerosis patients, while some companies are betting on being the first to develop the breakthrough blockbuster therapy. A step change in MS treatment is on the cards, explains Dr Andrea Taylor....
Please Login to read the full article.
18 June 2009
Dr Andrea Taylor
Please Login to read the full article.
RELATED CONTENT
FEATURES
- Face-to-face: The FDA, Amgen, and its blockbuster biologic, denosumab
- Roche's Asian partnering head looks to tap regional innovation
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
